Author

Laurent Peyrin-Biroulet 1

1 CHU Nancy

: THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Peyrin-Biroulet, Xavier Roblin

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollon Garcia, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James Lindsay, Laurent Peyrin-Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Geras

A MULTINATIONAL STUDY TO DETERMINE INDICATORS OF SUBOPTIMAL THERAPY AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS

James Lindsay, Javier Gisbert, Reema Mody, Laurent Peyrin-Biroulet, Alessandro Armuzzi, Bernd Bokemeyer, Geoffrey C. Nguyen, Jean Siebenaler, Örjan Åkerborg, Michael Smyth

A NOVEL SIMPLE SCORE FOR THE DIAGNOSIS OF CROHN’S DISEASE

Sieglinde Reinisch, Karin Schweiger, Eleonore Pablik, Benjamin Collet-Fenetrier, Laurent Peyrin-Biroulet, Julian Panés, Walter Reinisch

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A SELECTIVE, ORAL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD (APD334), IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE OASIS STUDY

William Sandborn, Laurent Peyrin-Biroulet, Luba Trokan, Jinkun Zhang, Tanja Kühbacher, Michael Chiorean, Scott D. Lee, Severine Vermeire, Bruce Yacyshyn, Snehal U. Naik, Preston Klassen, Julian Panés

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Raja Atreya, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie Lees, Edouard Louis, Milan Lukas, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun

AbbVie - Are we ready to change the course of IBD?

Edouard Louis, Remo Panaccione, Laurent Peyrin-Biroulet, Jean-Frederic Colombel

ACUTE INFUSION REACTIONS UNDER VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: RESULTS OF A MULTICENTER RETROSPECTIVE OBSERVATIONAL COHORT STUDY

chloé Venturin, Stéphane Nancey, Xavier Roblin, Laurent Peyrin-Biroulet, Nicolas Mathieu, Claire Gay, Pauline Danion, Remi Duclaux-Loras, Camille Meunier, Bernard Flourie, Gilles Boschetti

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre prospective, observational cohort study

Guillaume Pineton de Chambrun, Benjamin Pariente, Philippe Seksik, Romain Altwegg, Lucine Vuitton, Carmen Stefanescu, Stéphane Nancey, Alexandre Aubourg, Mélanie Serrero, Laurent Peyrin-Biroulet, Jerome Filippi, Stéphanie Viennot, Vered Abitbol, Medina Boualit, Arnaud Bourreille, Maria Nachury, Jacques Moreau, Anthony Buis

Item 1 - 10 / 222
1
2 3 4 5 6 7
...
22 23